Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer

This publication has 11 references indexed in Scilit:

• A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer
  Lung Cancer, 1994
• Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
  Journal of Clinical Oncology, 1994
• A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer
  Annals of Oncology, 1994
• Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial
  Annals of Oncology, 1994
• Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
  The Annals of Thoracic Surgery, 1993
• Cisplatin-mitomycin and vindesine in the treatment of inoperable non-small cell lung cancer Groupe Français de Pneumo-cancérologie (GFPC)
  European Journal Of Cancer, 1993
• A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung Cancer
  American Journal of Clinical Oncology, 1991
• A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group
  Cancer Chemotherapy and Pharmacology, 1990
• A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
  Journal of Clinical Oncology, 1986
• Reporting results of cancer treatment
  Cancer, 1981